Abatacept and rituximab increase cancer risk in patients with RA

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2036卷 / 1期
关键词：
D O I：
10.1007/s40278-024-71232-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] WHICH SERONEGATIVE RA PATIENTS RESPOND TO RITUXIMAB?
    Vital, E. M.
    Hensor, E. M.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 502 - 502
  • [22] OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB. AN OBSERVATIONAL COHORT STUDY
    Gron, Kathrine
    Glintborg, Bente
    Mehnert, Frank
    Ostergaard, Mikkel
    Dreyer, Lene
    Norgaard, Mette
    Krogh, Niels Steen
    Hetland, Merete L.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 630 - 630
  • [23] Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
    Gron, Kathrine Lederballe
    Arkema, Elizabeth V.
    Glintborg, Bente
    Mehnert, Frank
    Ostergaard, Mikkel
    Dreyer, Lene
    Norgaard, Mette
    Krogh, Niels Steen
    Askling, Johan
    Hetland, Merete Lund
    Askling, Johan
    Klareskog, Lars
    Feltelius, Nils
    Baecklund, Eva
    Sjowall, Christopher
    Rantapaa-Dahlqvist, Solbritt
    Forsblad-d'Elia, Helena
    Jacobsson, Lennart
    Turesson, Carl
    Lindqvist, Elisabet
    Nisell, Ralph
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (03) : 320 - 327
  • [24] Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab
    Chapman, Richard H.
    Smith, Daniel
    Semroc, Georgette N.
    Trivedi, Digisha N.
    Rosenblatt, Lisa C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S464 - S464
  • [25] No increased risk of cancer or death with cyclosporin in RA patients
    Reactions Weekly, 1998, 731 (1) : 5 - 5
  • [26] Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register
    Satis, Hasan
    Can, Gulce Ecem
    Salman, Reyhan Bilici
    Guler, Aslihan Avanoglu
    Karadeniz, Hazan
    Tufan, Abdurrahman
    RHEUMATOLOGY, 2019, 58 (08) : 1509 - 1510
  • [27] Abatacept Can be Used Safely for RA Patients with Interstitial Lung Disease
    Motojima, Shinji
    Nakashita, Tamao
    Jibatake, Akira
    Ando, Katsutoshi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S203 - S203
  • [28] The absence of secondary non-response in abatacept treated RA patients
    Saleem, Benazir
    Buch, Maya
    Conaghan, Phillip G.
    Emery, Paul
    RHEUMATOLOGY, 2008, 47 : II37 - II37
  • [29] ICIs increase risk of psoriasis in patients with cancer
    Reactions Weekly, 2024, 2034 (1) : 9 - 9
  • [30] Rheumatoid arthritis (RA) patients on tumor necrosis factor (TNF) blockers do not have an increase in risk of cancer.
    Maury, EE
    Reed, G
    Cassell, S
    Kavanaugh, A
    Kremer, J
    Hochberg, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4055 - 4055
12345